FDA DEVICE FACTS
PASCAL SYNTHESIS (532NM/577NM) OPTHALMIC LASER
Topcon Medical Laser Systems, Inc.
Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。
Indications for use
The PASCAL® Synthesis Ophthalmic Scanning Laser System is intended for use in the treatment of ocular pathology in-both the posterior and anterior segments. Intended for use in the posterior segment to perform retinal photocoagulation, panretinal photocoagulation, :focal photocoagulation and grid photocoagulation for vascular andstructural abnormalities of the retina andechoroid including: (532nm) * proliferative andnon-proliferative diabetic retinopathy " macular-edema * choroidal neovascularization associated with wet age-related macular degeneration * age-related macular degeneration * lattice degeneration * retinal tears anid detachments
(5 77nm) * proliferative and non-proliferative diabetic retinopathy * macular edema * choroidal neovascularization associated with wet age-related macular degeneration * age-related macular degeneration * lattice degeneration " retinal tears and detachments - Intended for use in the treatment of ocular pathology in the anterior segment including: (532 rn and 577nm) * iridotomy * trabeculoplasty
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。